Sfoglia per Autore
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis
2017-01-01 Lopetuso, L. R.; Jia, R.; Wang, X. -M.; Jia, L. -G.; Petito, V.; Goodman, W. A.; Meddings, J. B.; Cominelli, F.; Reuter, B. K.; Pizarro, T. T.
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders
2017-01-01 Lopetuso, L. R.; Petito, V.; Graziani, C.; Schiavoni, E.; Paroni Sterbini, F.; Poscia, A.; Gaetani, E.; Franceschi, F.; Cammarota, G.; Sanguinetti, M.; Masucci, L.; Scaldaferri, F.; Gasbarrini, A.
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis
2017-01-01 Menghini, P.; Di Martino, L.; Lopetuso, L. R.; Corridoni, D.; Webster, J. C.; Xin, W.; Arseneau, K. O.; Lam, M.; Pizarro, T. T.; Cominelli, F.
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea
2017-01-01 Lopetuso, L.; Graziani, C.; Guarino, A.; Lamborghini, A.; Masi, S.; Stanghellini, V.
Can we predict the efficacy of anti-TNF-α agents?
2017-01-01 Lopetuso, L. R.; Gerardi, V.; Papa, V.; Scaldaferri, F.; Rapaccini, G. L.; Gasbarrini, A.; Papa, A.
Gut microbiota and inflammatory bowel disease: So far so gut!
2017-01-01 Holleran, G.; Lopetuso, L. R.; Ianiro, G.; Pecere, S.; Pizzoferrato, M.; Petito, V.; Graziani, C.; Mcnamara, D.; Gasbarrini, A.; Scaldaferri, F.
Considering gut microbiota disturbance in the management of Helicobacter pylori infection
2018-01-01 Lopetuso, L. R.; Napoli, M.; Rizzatti, G.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A.
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver
2018-01-01 Lopetuso, L. R.; Mocci, G.; Marzo, M.; D’Aversa, F.; Rapaccini, G. L.; Guidi, L.; Armuzzi, A.; Gasbarrini, A.; Papa, A.
The use of probiotics in different phases of diverticular disease
2018-01-01 Ojetti, V.; Petruzziello, C.; Cardone, S.; Saviano, L.; Migneco, A.; Santarelli, L.; Gabrielli, M.; Zaccaria, R.; Lopetuso, L.; Covino, M.; Candelli, M.; Gasbarrini, A.; Franceschi, F.
Actinobacteria: A relevant minority for the maintenance of gut homeostasis
2018-01-01 Binda, C.; Lopetuso, L. R.; Rizzatti, G.; Gibiino, G.; Cennamo, V.; Gasbarrini, A.
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals
2018-01-01 Gibiino, G.; Lopetuso, L. R.; Scaldaferri, F.; Rizzatti, G.; Binda, C.; Gasbarrini, A.
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases
2018-01-01 De Sire, R.; Rizzatti, G.; Ingravalle, F.; Pizzoferrato, M.; Petito, V.; Lopetuso, L.; Graziani, C.; De Sire, A.; Mentella, M. C.; Mele, M. C.; Gasbarrini, A.; Scaldaferri, F.
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update
2018-01-01 Holleran, G.; Scaldaferri, F.; Ianiro, G.; Lopetuso, L.; Mc Namara, D.; Mele, M. C.; Gasbarrini, A.; Cammarota, G.
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel
2018-01-01 Trapani, V.; Petito, V.; Di Agostini, A.; Arduini, D.; Hamersma, W.; Pietropaolo, G.; Luongo, F.; Arena, V.; Stigliano, E.; Lopetuso, L. R.; Gasbarrini, A.; Wolf, F. I.; Scaldaferri, F.
Microbiota and inflammatory bowel disease: An update
2018-01-01 De Sire, R.; Talocco, C.; Petito, V.; Lopetuso, L. R.; Graziani, C.; Gasbarrini, A.; Scaldaferri, F.
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
2018-01-01 Lopetuso, L. R.; De Salvo, C.; Pastorelli, L.; Rana, N.; Senkfor, H. N.; Petito, V.; Di Martino, L.; Scaldaferri, F.; Gasbarrini, A.; Cominelli, F.; Abbott, D. W.; Goodman, W. A.; Pizarro, T. T.
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions
2018-01-01 Ianiro, G.; Masucci, L.; Quaranta, G.; Simonelli, C.; Lopetuso, L. R.; Sanguinetti, M.; Gasbarrini, A.; Cammarota, G.
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats
2018-01-01 Posteraro, B.; Paroni Sterbini, F.; Petito, V.; Rocca, S.; Cubeddu, T.; Graziani, C.; Arena, V.; Vassallo, G. A.; Mosoni, C.; Lopetuso, L.; Lorrai, I.; Maccioni, P.; Masucci, L.; Martini, C.; Gasbarrini, A.; Sanguinetti, M.; Colombo, G.; Addolorato, G.
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials
2018-01-01 Ianiro, G.; Rizzatti, G.; Plomer, M.; Lopetuso, L.; Scaldaferri, F.; Franceschi, F.; Cammarota, G.; Gasbarrini, A.
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease
2018-01-01 Gaetani, E.; Zompo, F. D.; Marcantoni, M.; Gatto, I.; Giarretta, I.; Porfidia, A.; Scaldaferri, F.; Laterza, L.; Lopetuso, L.; Gasbarrini, A.; Pola, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis | 2017 | Lopetuso, L. R.; Jia, R.; Wang, X. -M.; Jia, L. -G.; Petito, V.; Goodman, W. A.; Meddings, J. B.; Cominelli, F.; Reuter, B. K.; Pizarro, T. T. | |
| Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders | 2017 | Lopetuso, L. R.; Petito, V.; Graziani, C.; Schiavoni, E.; Paroni Sterbini, F.; Poscia, A.; Gaetani, E.; Franceschi, F.; Cammarota, G.; Sanguinetti, M.; Masucci, L.; Scaldaferri, F.; Gasbarrini, A. | |
| A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis | 2017 | Menghini, P.; Di Martino, L.; Lopetuso, L. R.; Corridoni, D.; Webster, J. C.; Xin, W.; Arseneau, K. O.; Lam, M.; Pizarro, T. T.; Cominelli, F. | |
| Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea | 2017 | Lopetuso, L.; Graziani, C.; Guarino, A.; Lamborghini, A.; Masi, S.; Stanghellini, V. | |
| Can we predict the efficacy of anti-TNF-α agents? | 2017 | Lopetuso, L. R.; Gerardi, V.; Papa, V.; Scaldaferri, F.; Rapaccini, G. L.; Gasbarrini, A.; Papa, A. | |
| Gut microbiota and inflammatory bowel disease: So far so gut! | 2017 | Holleran, G.; Lopetuso, L. R.; Ianiro, G.; Pecere, S.; Pizzoferrato, M.; Petito, V.; Graziani, C.; Mcnamara, D.; Gasbarrini, A.; Scaldaferri, F. | |
| Considering gut microbiota disturbance in the management of Helicobacter pylori infection | 2018 | Lopetuso, L. R.; Napoli, M.; Rizzatti, G.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A. | |
| Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver | 2018 | Lopetuso, L. R.; Mocci, G.; Marzo, M.; D’Aversa, F.; Rapaccini, G. L.; Guidi, L.; Armuzzi, A.; Gasbarrini, A.; Papa, A. | |
| The use of probiotics in different phases of diverticular disease | 2018 | Ojetti, V.; Petruzziello, C.; Cardone, S.; Saviano, L.; Migneco, A.; Santarelli, L.; Gabrielli, M.; Zaccaria, R.; Lopetuso, L.; Covino, M.; Candelli, M.; Gasbarrini, A.; Franceschi, F. | |
| Actinobacteria: A relevant minority for the maintenance of gut homeostasis | 2018 | Binda, C.; Lopetuso, L. R.; Rizzatti, G.; Gibiino, G.; Cennamo, V.; Gasbarrini, A. | |
| Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals | 2018 | Gibiino, G.; Lopetuso, L. R.; Scaldaferri, F.; Rizzatti, G.; Binda, C.; Gasbarrini, A. | |
| Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases | 2018 | De Sire, R.; Rizzatti, G.; Ingravalle, F.; Pizzoferrato, M.; Petito, V.; Lopetuso, L.; Graziani, C.; De Sire, A.; Mentella, M. C.; Mele, M. C.; Gasbarrini, A.; Scaldaferri, F. | |
| Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update | 2018 | Holleran, G.; Scaldaferri, F.; Ianiro, G.; Lopetuso, L.; Mc Namara, D.; Mele, M. C.; Gasbarrini, A.; Cammarota, G. | |
| Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel | 2018 | Trapani, V.; Petito, V.; Di Agostini, A.; Arduini, D.; Hamersma, W.; Pietropaolo, G.; Luongo, F.; Arena, V.; Stigliano, E.; Lopetuso, L. R.; Gasbarrini, A.; Wolf, F. I.; Scaldaferri, F. | |
| Microbiota and inflammatory bowel disease: An update | 2018 | De Sire, R.; Talocco, C.; Petito, V.; Lopetuso, L. R.; Graziani, C.; Gasbarrini, A.; Scaldaferri, F. | |
| IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair | 2018 | Lopetuso, L. R.; De Salvo, C.; Pastorelli, L.; Rana, N.; Senkfor, H. N.; Petito, V.; Di Martino, L.; Scaldaferri, F.; Gasbarrini, A.; Cominelli, F.; Abbott, D. W.; Goodman, W. A.; Pizarro, T. T. | |
| Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions | 2018 | Ianiro, G.; Masucci, L.; Quaranta, G.; Simonelli, C.; Lopetuso, L. R.; Sanguinetti, M.; Gasbarrini, A.; Cammarota, G. | |
| Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats | 2018 | Posteraro, B.; Paroni Sterbini, F.; Petito, V.; Rocca, S.; Cubeddu, T.; Graziani, C.; Arena, V.; Vassallo, G. A.; Mosoni, C.; Lopetuso, L.; Lorrai, I.; Maccioni, P.; Masucci, L.; Martini, C.; Gasbarrini, A.; Sanguinetti, M.; Colombo, G.; Addolorato, G. | |
| Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials | 2018 | Ianiro, G.; Rizzatti, G.; Plomer, M.; Lopetuso, L.; Scaldaferri, F.; Franceschi, F.; Cammarota, G.; Gasbarrini, A. | |
| Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease | 2018 | Gaetani, E.; Zompo, F. D.; Marcantoni, M.; Gatto, I.; Giarretta, I.; Porfidia, A.; Scaldaferri, F.; Laterza, L.; Lopetuso, L.; Gasbarrini, A.; Pola, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile